Primary aldosteronism: Analysis of a series of 54 patients;Hiperaldosteronismo primario: Análisis de una serie de 54 pacientes

Medicina Clinica

Volumn 124, Issue 20, 2005, Pages 765-768

  Sabio, José Mario ^a   Mediavilla García, Juan Diego ^a   Jaén, Fernando ^a   Fernández Torres, Celia ^a   Aliaga, Luis ^a   Jiménez Alonso, Juan ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

Aldosterone; Aldosterone producing adenoma; Bilateral adrenal hyperplasia; Primary aldosteronism; Renin; Spironolactone

Indexed keywords

SPIRONOLACTONE;

ADENOMA; ADRENAL HYPERPLASIA; ADRENAL SCINTISCANNING; ADRENAL TUMOR; ADRENALECTOMY; ADULT; AGED; ALDOSTERONE PRODUCING ADENOMA; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; FEMALE; HUMAN; HYPERTENSION; HYPOKALEMIA; MAJOR CLINICAL STUDY; MALE; NODULAR BILATERAL HYPERPLASIA; NODULAR UNILATERAL HYPERPLASIA; PREVALENCE; PRIMARY HYPERALDOSTERONISM; SEX DIFFERENCE; SEX RATIO;

EID: 21244464812     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13075846     Document Type: Article

References (15)

1. Stowasser M. Primary aldosteronism. J Hypertens. 2001;19:363-6.
2. Lim PO, Rodgers P, Cardale K, Watson AD, MacDonald TM. Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet. 1999;353:40.
3. Loh KC, Okay ES, Khaw MC, Emmanuel SC, Young WF Jr. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab. 2000;85:2854-9.
4. Rayner BL, Opie LH, Davidson JS. The aldosterone/rennin ratio as a screening test for primary aldosteronism. South African Med J. 2000;90: 394-400.
5. Montori VM, Schwartz GL, Chapman AB, Boerwinkle E, Turner ST. Validity of the aldosteronarenbin ratio used to screen for primary aldosteronism. Mayo Clin Proc. 2001;76:877-82.
6. Schwartz GL, Chapman AB, Boerwinkle E, Kkisabeth RM, Turner ST. Screening for primary aldosteronism: implications of an increased plasma aldosterona/rennin ratio. Clin Chem. 2002; 48:1919-23.
7. Benchetrit S, Bernheim J, Podjarny E. Normokalemic hyperaldosteronism in patients with resistant hypertension. IMAJ. 2002;4:17-20.
8. Mosso L, Carvajal C, González A, Barraza A, Ávila F, Montero J, et al. Primary aldosteronism and hypertensive disease. Hypertension. 2003;42:161-5.
9. Stowasser M, Gordon MD, Gunasekera TG, Cowley DC, Ward G, Archivald C, et al. High rate of detection of primary aldosteronism, including surgically treatable forms, after «non-selective» screening of hypertensive patients. J Hypertens. 2003;21:2149-57.
10. Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension. 2002;40:892-6.
11. Lim PO, Jung RT, MacDonald TM. Raised aldosterona to rennin ratio predicts anti-hypertensive efficacy of spirololactone. A prospective cohort follow-up study. Br J Clin Pharmacol. 1999;48:756-60.
12. Lim PO, Young WF, MacDonald TM. A review of the medical treatment of primary aldosteronism. J Hypertens. 2001;19:353-61.
13. Stowasser M. Primary aldosteronism: revival of a syndrome. J Hypertens. 2000;18:363-6.
14. Espiner EA, Ross DG, Ynadle TG, Richards AM, Hunt J. Predicting surgically remedial primary aldosteronism: role of adrenal scanning, posture testing, and adrenal vein sampling. J Clin Endocrinol Metab. 2003;88:3637-44.
15. Ghose RP, Hall PM, Bravo EL. Medical management of aldosterona-producing adenomas. Ann Intern Med. 1999;131:105-8.